SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-114413
Filing Date
2022-11-03
Accepted
2022-11-03 16:05:27
Documents
15
Period of Report
2022-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229578d1_8k.htm   iXBRL 8-K 33304
2 EXHIBIT 3.1 tm2229578d1_ex3-1.htm EX-3.1 234336
3 EXHIBIT 99.1 tm2229578d1_ex99-1.htm EX-99.1 103075
7 GRAPHIC tm2229578d1_ex99-1img001.jpg GRAPHIC 12187
  Complete submission text file 0001104659-22-114413.txt   626263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rigl-20221028.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20221028_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20221028_pre.xml EX-101.PRE 22589
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2229578d1_8k_htm.xml XML 3619
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 221357901
SIC: 2834 Pharmaceutical Preparations